Company in Medical Technology

European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK

CLEVELAND, July 28 /PRNewswire-FirstCall/ -- DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that a European Division within a Global Top 20 Pharmaceutical organization has selected DA...

Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies

GORDONSVILLE, Va., June 24 /PRNewswire/ -- PBM Products, LLC, a leading infant formula company that supplies store-brand infant formulas to Walmart, Sam's Club, Target, Kroger, CVS, Walgreens, and other retailers, has partnered with the University of Virginia (U.Va.) to conduct clinical studies ...

Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial

Results show improved insulin sensitivity and lower glucose levels without the side effects of current therapies KALAMAZOO, Mich., May 14 /PRNewswire/ -- Metabolic Solutions Development Company (MSDC) announced today that its lead compound, MSDC-0160, can improve insulin sensitivity and lo...

Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma

LACHEN, Switzerland, May 1 /PRNewswire/ -- - Company Working With Authorities to Ensure Adequate Supply of Virally Inactivated Plasma Derivatives The impending influenza pandemic will have implications for global stocks of life-saving blood and blood products, warns Swiss-based g...

Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments

NEW BRUNSWICK, N.J., March 23 /PRNewswire/ -- Each year in the United States more than 138,000 people are diagnosed with leukemia, lymphoma or myeloma. These new cases account for 10 percent of the new total cancer cases in the U.S. per year. For several types of leukemia, the survival rate has ...

BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference

LYNBROOK, N.Y., March 10 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the upcoming Cowen ...

Ikaria(R) Named Private Company of the Year by New Jersey Technology Council

CLINTON, N.J., Nov. 21 /PRNewswire/ -- Ikaria Holdings, Inc. today announced that it has been named Private Company of the Year by the New Jersey Technology Council (NJTC), a 1,200-member non-profit organization that provides business support, networking opportunities, information and advocacy for...

Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio

Review Zanolimumab Program to be Discontinued and Headcount to be Reduced Summary: Genmab Announces the Results of its Portfolio Review; Zanolimumab Program to be Discontinued and the Company Will Reduce the Number of Employees COPENHAGEN, October 8 /PRNewswire-F...

Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation

DURHAM, N.C., Aug. 19 /PRNewswire/ -- Addrenex Pharmaceuticals ( http://www.addrenex.com ) has made three strategic hires this month to further its goal of identifying and developing as many new drug candidates as possible over the next 18 months. The fast-paced timeline they have set for ...

Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study

COPENHAGEN, Denmark, July 9 /PRNewswire-FirstCall/ -- Summary: Genmab has completed recruitment of patients in the Phase II study of ofatumumab in combination with fludarabine and cyclophosphamide to treat front line CLL. Genmab A/S (OMX: GEN) announced today it has completed recruitment of ...

Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study

COPENHAGEN, Denmark, June 10 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today a Phase I/II study to evaluate a subcutaneous route of administration of ofatumumab (HuMax-CD20(R)) in rheumatoid arthritis (RA) patients, stable on methotrexate will be initiated soon. The study, whic...

Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Maryland's Emerging Company of the Year Award

ROCKVILLE, Md., May 19 /PRNewswire-USNewswire/ -- On Thursday May 15, 2008 Sanaria Inc. was named Emerging Company of the Year at the annual Technology Council of Maryland's Tech Awards Celebration honoring the state's technology leaders and organizations. http://techcouncilmd.com/News/tcmn...

Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS

COPENHAGEN, April 15 /PRNewswire-FirstCall/ -- Summary: Genmab has announced that HuMax-EGFr (zalutumumab) inhibits epidermal growth factor receptor signaling by locking epidermal growth factor receptor (EGFr) molecules into a very compact, inactive conformation. The flexibility of the EGFr is...

Maine Natural Health Company Conducts Dental Clinical Trial

OmegaMaine(TM) Omega-3 oil may improve gum health ROCKPORT, Maine, Feb. 12 /PRNewswire/ -- The Maine Natural Health Company is working with dentists and their patients to study the effects of OmegaMaine(TM) Omega-3 oil as it pertains to inflammation and gum health. (Photo: http:/...

The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh

Cognition Therapeutics, Inc. Begins Operations with a $200,000 Investment from the PLSG PITTSBURGH, Dec. 4 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business gro...

Female Health Company Receives Brazilian Order: Four Million FC Female Condoms

CHICAGO, Nov. 14 /PRNewswire-FirstCall/ -- The Female Health Company (Amex: FHC ) today announced that it has received an order for four million FC Female Condoms from the Brazilian Ministry of Health. It is anticipated that shipments will begin in early calendar 2008. Brazil is recognized b...

Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference

NEW YORK, Oct. 1 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced that I. Craig Henderson, MD, the Company's President, will present an overview of the Company's cancer pipeline at the upcoming William Blair & Company Small-Cap Growth Stock Conference i...

Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity

BOTHELL, Wash., Oct. 1 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK ) announced today the start of a Phase 2 clinical trial evaluating the Company's PYY3-36 Nasal Spray in obese patients. The study will enroll approximately 500 obese patients for a six-month, ra...

Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes

- Rapid-Acting, Non-Invasive Nasal Spray Dosage form is Patient Friendly and Avoids Potential Safety Concerns of Pulmonary Delivery - BOTHELL, Wash., Sept. 26 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK ) announced today the start of a Phase 2 clinical tri...

The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units

CHICAGO, Sept. 10 /PRNewswire-FirstCall/ -- The Female Health Company (Amex: FHC ) announced it has signed a contract with John Snow, Inc., which implements the USAID | DELIVER PROJECT, for the delivery of five million female condoms (FC) for United States Agency for International Development...

New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs

MELBOURNE, Australia, Aug. 28 /PRNewswire/ -- Cancer Therapeutics CRC Pty Ltd (CTx) has commenced operations as one of the largest public/private partnerships of its type in the world. Underpinned by AUD$148 million in funding over seven years, including AUD$37.6 million from the Australian C...

Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company

Company Focuses Operations, Updates Zingo Launch Progress and Adlea Registration Strategy Conference Call Today at 11:30 am ET SOUTH SAN FRANCISCO, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) announced today that the compa...

Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company

Company Intends to Request Meeting with FDA Regarding Possible Phase III Trial Based on Human Data Demonstrating Bioequivalence of INS-19 to Neupogen(R) RICHMOND, Va., July 10, 2008 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM ), a developer of follow-on b...

IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company

IRVINE, Calif., Dec. 14 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI ) today provided an update of the three lead programs in its product pipeline, mifamurtide (L-MTP-PE), UVIDEM(R) and IDM-2101. Mifamurtide (L-MTP-PE) IDM Pharma continues to work with European regulators resp...

Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company

Statement by Sandra C. Raymond, President & CEO of the Lupus Foundation of America, Inc. WASHINGTON, June 27, 2007 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, Inc. and more than 1.5 million Americans with lupus have been awaiting the preliminary findings of the Phase III clinic...

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

...ld be a huge advance in how we currently treat cancer," Dr. Murphree said. This work is done in conjunction with Ricardo Carvalho, M.D., Ph.D. and the company 3T Ophthalmics which is developing the drug delivery system. The episcleral drug reservoir is inserted under the thin, filmy conjunctiva, or co...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

...RONEXT: SAN and NYSE: SNY ), announced today the company has submitted to the U.S. Food and Drug Administra...more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and de...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...esult of the significant upfront payments that the company received from its strategic alliance with Genzyme ... value that Isis is recognizing from its satellite company strategy. Net Income (Loss) from Disc... reduction in tumor markers. Eli Lilly and company recently completed its Phase 1 study of LY2181308 ...

SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite

... operations soon to have the system working in all geographies in which the company has operations. About SIRO SIRO Clinpharm Private Limited (SI...which caters to the needs of pharmaceutical companies across the world. The company has offices in India, USA, Israel and in Germany, Romania, Estonia and Gree...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... enter long-term care, and half of this group never returns to living independently. About Radius (www.radiuspharm.com) Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. Radius has raised $106.5 million in privat...

NewCardio Announces Master Services Agreement With Dedicated Phase I

...sed cardiac safety for the pharmaceutical industry and drug regulators. The company believes that its QTinno(TM), software-based, analytical technology is the ... About NewCardio, Inc. NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

...nder regulatory review in the U.S. by the FDA. The company also has a robust pipeline of follow-on products i...ntegrated, international, specialty pharmaceutical company with the capability to internally develop and comm...t to rely on these forward-looking statements. The company disclaims any obligation to update these forward-l...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

...in from the U.S. Centers for Disease Control. The company was able to reach this manufacturing goal by emplo...ntial reagents for measuring vaccine potency. The company also has plans to produce additional batches of th...h a VLP based seasonal flu vaccine candidate. The company plans to initiate a Phase II study with its Season...

2,500 Cases Completed With the Magnetic Irrigated Catheter

...sks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will re...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

... Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylat...forms to improve and enable molecules. The company recently announced positive Phase 2 results for Or...dates or complex commercial agreements; (v) if the company is unable to establish and maintain collaboration ...

DNA Helps Reunite Children With Their Families

...o to http://www.hsc.unt.edu/ About Life Technologies Life Technologies Corporation (Nasdaq: LIFE ) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to ...

Study Shows Brain Fitness can Save Medicare Billions

...osit Science is the leader in clinically proven brain fitness programs. The company works with over 50 scientists from prestigious universities to design and t...Posit Science is a registered trademark of Posit Science Corporation. Other company and product names may be trademarks of their respective owners. ...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

...apeutics, Inc. (Mercury), a privately held biotech company based in Woburn, Massachusetts focusing on the dev...llaboration with an experienced innovative biotech company like Mercury. Diabetes is a major cause of morbidi..., Mercury Therapeutics is a privately held biotech company focusing on the development of AMPK activators as ...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

...ormation on TELINTRA is available at www.telik.com . About Telik Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer and inflammatory diseases. The company's most advanced investigational dru...

Project Zero Delay Accelerates Drug's Path to Clinical Trial

...trial, a milestone that normally takes three to six months. Investigators from The University of Texas M. D. Anderson Cancer Center and pharmaceutical company AstraZeneca have reported their work in the Journal of Clinical Oncology published online on August 3(rd). The joint effort, dubbed Project...